GATA3 and T-box family transcription factor (T-bet) are Th1 and Th2 cell differentiation markers, respectively, and T-bet-positive PTCL has a better prognosis than GATA3-positive PTCL (66, 67). This evidence concerns the gene GATA3 and mature T-cell and NK-cell non-Hodgkin lymphoma.